Typhoid vaccine trial confirms sustained protection for older children — University of Oxford, Medical Sciences Division

The TyVOID study, published in the Lancet, measured the effectiveness of a single dose TCV in Bangladeshi children.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer — University of Oxford, Medical Sciences Division

The research addresses the long-recognized poor prognosis of relatively undifferentiated cancers, suggesting that selection against.

Four Oxford researchers win prestigious Philip Leverhulme Prizes — University of Oxford, Medical Sciences Division

Only 30 prizes are awarded throughout the UK each year, with the 2024 prizes covering.

Kavli Oxford’s Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition — University of Oxford, Medical Sciences Division

The Nikon Small World competition, often referred to as the ‘Oscars of microscopy,’ is one.

Ineos Oxford Institute awards over £2m to innovative projects to tackle antimicrobial resistance — University of Oxford, Medical Sciences Division

The IOI Synergy Grants scheme is an internal Oxford-wide funding call for AMR-focused research with.

The Translational Research Immunology Group (TRIG) celebrates huge success at International Congress of The Transplantation Society

Nora Atallah and Professor Fadi Issa received a Mentee-Mentor Award, and Oliver McCallion, Sarah Short,.

Leading academics and innovators join refreshed BioEscalator Management Board — University of Oxford, Medical Sciences Division

Peter Callow is a seasoned finance executive with extensive international experience in financial management, strategic planning,.

Treating bullying as everyone’s problem reduces incidence in primary schools — University of Oxford, Medical Sciences Division

The year-long trial of the KiVa school based bullying prevention programme was implemented in over.

MyMelanoma study selected to join NHS DigiTrials initiative — University of Oxford, Medical Sciences Division

Launched in 2023, the MyMelanoma study is the most ambitious melanoma research project undertaken in the UK..

Launch of the new BHF Oxford Centre of Research Excellence — University of Oxford, Medical Sciences Division

The new BHF Oxford Centre of Research Excellence (BHF Oxford CRE) has launched today at the University.